Japan grants orphan drug designation to Lynparza for BRCA+ unresectable pancreatic cancer
March 19, 2020Research and Development, Sales and Marketing AstraZeneca, Japan, lynparza, pharma
AstraZeneca has confirmed that its PARP inhibitor Lynparza (olaparib) has been awarded orphan drug designation in Japan for the maintenance …
EMA calls on EU to pool resources together to carry out large scale clinical trials against COVID-19
March 19, 2020Business Services COVID-19, Chinese Coronavirus, Wuhan Coronavirus, coronavirus
The European Medicines Agency (EMA) has called on the European Union to collaborate closely on carrying out clinical trials on …
Japan approves Novartis’ Zolgensma for spinal muscular atrophy in patients under two years old
March 19, 2020Sales and Marketing Japan, Novartis, Zolgensma, pharma, spinal muscular atrophy
Novartis has revealed that its gene therapy Zolgensma (onasemnogene abeparvovec) has secured approval from Japan’s Ministry of Health, Labour and …
COVID-19 can survive in aerosol form and on hard surfaces from hours to days, new study shows
March 19, 2020Business Services COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus
New research shows that the COVID-19 coronavirus is stable for hours to days in aerosols and on surfaces. This study was …
NICE and EMA to review if Ibuprofen and other anti-inflammatories worsen coronavirus
March 19, 2020Business Services British Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus
The National Institute for Health and Care Excellence (NICE) and the European Medicines Regulatory have both stated that there is …
Global drug spending projected to reach $1.1 trillion by 2024, report argues
March 18, 2020Research and Development, Sales and Marketing IQVIA, pharma, report
Total global spending on medicines is set to break $1.1 trillion by 2024, a new report released by IQVIA has …
Fujifilm flu drug effective in treating coronavirus in Chinese clinical trials
March 18, 2020Research and Development COVID-19, Wuhan Coronavirus, coronavirus
A flu drug has appeared to be effective in treating COVID-19, according to recent clinical trials in China. The drug, …
100 coronavirus cases linked to Biogen-hosted event in Boston, State of Massachusetts confirms
March 18, 2020Manufacturing and Production, Medical Communications, Research and Development Biogen, coronavirus, pharma
It is now known that around 100 of the known cases of the COVID-19 coronavirus can be traced to an …
$63bn Allergan/AbbVie merger review could be delayed by coronavirus
March 18, 2020Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Allergan, merger, pharma
The $63 billion merger of major pharma players AbbVie and Allergan could be facing hurdles on the road to regulatory …
NICE promotes Professor Gillian Leng as its new Chief Executive
March 18, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK, pharma
NICE, the drug watchdog for the NHS in England and Wales, has announced that it has promoted Professor Gillian Leng …
New technologies and industry collaboration will help fight chronic illnesses
March 17, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, pharma
Authored by Dan Boot, Head of Digital Innovation at RB Health.Around the world, populations are aging. According to the World …
European Commission offers €80m to CureVac to develop coronavirus vaccine
March 17, 2020Manufacturing and Production, Research and Development, Sales and Marketing CureVac, EU, US, coronavirus
Following confirmation of reports that US President Donald Trump sought to persuade a biotech to provide US-exclusivity for a potential …
Novo Nordisk halts three haemophilia studies after participants suffer thrombotic events
March 17, 2020Manufacturing and Production, Research and Development Novo Nordisk, haemophilia, pharma
Novo Nordisk has moved to temporarily shut down two of its Phase 3 and one of its Phase 2 clinical …
Success and failure at Phase 3 for AstraZeneca’s Imfinzi combos in first-line small cell lung cancer
March 17, 2020Manufacturing and Production, Research and Development AstraZeneca, Cancer, Imfinzi, pharma
AstraZeneca has pulled back the curtain on new Phase 3 data for Imfinzi (durvalumab) in the first-line treatment of extensive-stage …
FDA gives emergency authorisation to first coronavirus tests
March 17, 2020Manufacturing and Production, Sales and Marketing FDA, Roche, US, coronavirus
The coronavirus crisis in the US has thus far been characterised by a lack of testing within its population. This …
Human dosing begins for first US coronavirus vaccine
March 17, 2020Manufacturing and Production, Research and Development Moderna, Vaccine, coronavirus, pharma
The race to develop a vaccine against the ongoing outbreak of novel coronavirus has stepped up with the news that …
Genmab announces newly-created Chief Financial Officer appointment
March 16, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genmab, pharma
Genmab has announced the establishment of the new position of Chief Operating Officer at the company, and has furthermore named …
Trump tried to solicit US-exclusivity for coronavirus vaccine, report claims
March 16, 2020Sales and Marketing CureVac, Trump, US, coronavirus, pharma
President Trump has attracted criticism from all sides over his response to the novel coronavirus outbreak; after repeatedly downplaying the …
Bavencio Phase 3 head and neck cancer trial terminated
March 16, 2020Research and Development, Sales and Marketing Bavencio, Cancer, EMD Serono, Merck KGaA, Pfizer, trial failure
Merck KGaA, its biopharma division EMD Serono, and Pfizer have announced their decision to terminate their ongoing Phase 3 trial …
NHS England to supply HIV prevention drug PrEP with £16m government investment
March 16, 2020Manufacturing and Production, Sales and Marketing NHS, NHS England, PrEP HIV, PrEP< HIV, UK, pharma
NHS England is set to fund the availability of pre-exposure prophylaxis (PrEP) for the prevention of HIV for local authorities …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
